Columbus Circle Investors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-57,310
| Closed | -$1.03M | – | 262 |
|
|
2017
Q3 | $1.03M | Sell |
57,310
-12,794
| -18% | -$229K | 0.02% | 241 |
|
|
2017
Q2 | $1.14M | Sell |
70,104
-20,945
| -23% | -$341K | 0.02% | 216 |
|
|
2017
Q1 | $1.28M | Buy |
91,049
+5,742
| +7% | +$80.4K | 0.02% | 236 |
|
|
2016
Q4 | $1.36M | Buy |
85,307
+1,196
| +1% | +$19.1K | 0.02% | 225 |
|
|
2016
Q3 | $1.4M | Buy |
84,111
+17,633
| +27% | +$293K | 0.02% | 238 |
|
|
2016
Q2 | $744K | Sell |
66,478
-38,096
| -36% | -$426K | 0.01% | 238 |
|
|
2016
Q1 | $874K | Buy |
+104,574
| New | +$874K | 0.01% | 238 |
|
|
2015
Q4 | – | Sell |
-47,258
| Closed | -$533K | – | 295 |
|
|
2015
Q3 | $533K | Buy |
+47,258
| New | +$533K | ﹤0.01% | 259 |
|
|
2014
Q1 | – | Sell |
-196,358
| Closed | -$2.44M | – | 327 |
|
|
2013
Q4 | $2.44M | Buy |
196,358
+155,951
| +386% | +$1.94M | 0.02% | 260 |
|
|
2013
Q3 | $442K | Buy |
40,407
+7,907
| +24% | +$86.5K | ﹤0.01% | 288 |
|
|
2013
Q2 | $263K | Buy |
+32,500
| New | +$263K | ﹤0.01% | 274 |
|